Antimicrobial therapy in dermatology

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Cord SunderkötterUta Jappe

Abstract

The extensive and sometimes indiscriminate use of antibiotics sometimes without strict indications has led to increases in both bacterial resistance and sensitization of patients. Systemic antibiotics in skin infections are indicated when a severe local infection occurs which spreads into the surrounding tissue or when there are signs of systemic infection. There are special indications in patients with peripheral arterial occlusive disease,diabetes or immunosuppression. Topical use of antibiotics should be abandoned and replaced by antiseptics. The beta-lactam antibiotics are the antibiotics of first choice for many skin infections. They are usually effective, have a well-defined profile of adverse events and most are affordable. Penicillin G or V are the first line treatment for erysipelas. Infections with Staphylococcus aureus are usually treated with isoxazolyl penicillins or second generation cephalosporins. In mixed infections in patients with diabetes or peripheral arterial occlusive disease,the treatment of choice is metronidazole plus beta-lactam-/beta-lactamase inhibitor antibiotics, but quinolones or second generation cephalosporins can also be used, once again with metronidazole. The aim of this review is to define ...Continue Reading

References

Mar 1, 1979·Annals of Internal Medicine·H C Neu
Jan 1, 1977·Journal of Clinical Pathology·G A AyliffeE J Lowbury
Mar 14, 1992·Lancet·C K FairleyJ McNeil
Sep 25, 1992·Biochemical Pharmacology·W PruzanskiP Vadas
Jun 1, 1987·The Journal of Infectious Diseases·R J DattwylerB J Luft
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L StevensS P Hackett
Apr 1, 1995·Enfermedades infecciosas y microbiología clínica
May 1, 1994·Allergy·J M VegaS Terrados
Nov 1, 1995·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Boguniewicz
Jun 1, 1997·Journal of Chemotherapy·P BallG Rolinson
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A TalanS M Finegold
Dec 12, 2000·The Journal of Allergy and Clinical Immunology·A RomanoM Blanca
Sep 15, 2001·The New England Journal of Medicine·P S Kelkar, J T Li
Dec 31, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Joseph A Paladino
Mar 26, 2003·The British Journal of Dermatology·J I RossJ H Cove
Feb 28, 2004·Journal of the American Academy of Dermatology·Eric S Schweiger, Jeffrey M Weinberg
Mar 24, 2004·Health Policy·Tal Gilbert, Leah Gilbert
Aug 4, 2004·The Lancet Infectious Diseases·Adam M BresslerJyoti Somani
Sep 10, 2004·The New England Journal of Medicine·Wayne A RayC Michael Stein
Oct 12, 2005·Archives of Medical Research·Alfonso J Alanis

❮ Previous
Next ❯

Citations

Oct 3, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Falk Ochsendorf
Oct 27, 2011·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Helmut SchöferUNKNOWN Paul Ehrlich Society for Chemotherapy (PEG)
Feb 20, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C Sunderkötter, K Becker
Feb 20, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C SunderkötterK Becker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.